Scott Adams Ely, M.D.

Publications

Geyer JT, Niesvizky R, Jayabalan DS, Mathew S, Subramaniyam S, Geyer AI, Orazi A, Ely SA: IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol doi: 10.1038/modpathol.2013.159. [Epub ahead of print], 2013.

Nardiello, Tricia, Jungbluth, Achim A., Mei, Anna, DiLiberto, Maurizio, Huang, Xiangao, Dabrowski, Ania, Andrade, Valeria C.C., Wasserstrum, Rebecca, Ely, Scott, Niesvizky, Ruben, Pearse, Roger, Coleman, Morton, Jayabalan, David S., Bhardwaj, Nina, Old, Lloyd J., Chen-Kiang, Selina, Cho, Hearn Jay. MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin. Clinical cancer research. 2011;17:4309-4319.

Subramaniyam S, Fraser CR, Rao PH, Feldman E, Ely S, Mathew S. De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13. Leukemia & lymphoma. 2011;52:2195-2199.

John P. Leonard, Ann S. LaCasce, Mitchell R. Smith, Ariela Noy, Lucian R. Chirieac, Scott J. Rodig, Jian Q. Yu, Shankar Vallabhajosula, Steven M. Larson, Heiko Schoder, Patricia English, Donna S. Neuberg, Peter Martin, Michael M. Millenson, Scott A. Ely, Rachel Courtney, Naveed Shaik, Keith D. Wilner, Sophia Randolph, Annick D. Van den Abbeele, Selina Y. Chen-Kiang, Jeffrey T. Yap and Geoffrey I. Shapiro. Selective CDK4/6 Inhibition and Tumor Responses are Induced by PD0332991 In Patients with Mantle Cell Lymphoma.  Accepted for publication in Blood, January, 2012

 

Back to topBack To Top